Isoform-Selective ATAD2 chemical probe with novel chemical structure and unusual mode of action

October 18, 2017

Fernández-Montalván, A., Berger, M., Kuropka, B., et al.

American Chemical Society 2017, vol: 12(11) doi: 10.1021/acschembio.7b00708

Abstract

ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types. Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that specifically induces ATAD2 bromodomain dimerization and prevents interactions with acetylated histones in vitro, as well as with chromatin in cells. These features qualify BAY-850 as a chemical probe to explore ATAD2 biology.

View Publication
 

Topics: Monolith – MicroScale Thermophoresis, MST,  Publications

 

 

 

Previous Article
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies

Up next
The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity
The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity

Ready to characterize your most challenging interactions?

Discover tools to measure binding affinity

Learn more